Standex International Corporation SXI
280.17
0.57
0.20%
as of 25 Sep
- Market cap
- $3.4B
- P/E
- 32.2×
Follow SXI
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
48.27 | 48.39 | 30.97 | 41.11 |
P/S ratio |
3.04 | 3.01 | 3.47 | 4.83 | |
P/FCF ratio |
62.38 | 50.70 | 56.55 | 66.90 | |
P/Operating CF |
151.29 | 127.28 | 261.39 | 106.49 | |
P/B ratio |
3.60 | 3.74 | 4.07 | 5.70 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
3.57 | 3.52 | 3.88 | 5.21 | |
EV/EBITDA |
21.79 | 18.42 | 14.95 | 20.00 | |
EV/Operating CF |
43.45 | 38.02 | 41.67 | 51.86 | |
EV/FCF |
73.30 | 59.18 | 63.35 | 72.17 | |
Quick Ratio |
1.56 | 1.60 | 1.79 | 1.53 | |
Current Ratio |
2.87 | 2.87 | 3.05 | 2.40 | |
Net Debt/EBITDA |
11.30 | 9.61 | 3.68 | 7.22 | |
Debt/Assets |
35.03% | 34.40% | 30.97% | 32.66% | |
Debt/Equity |
0.77 | 0.76 | 0.63 | 0.69 | |
Asset Turnover |
0.65 | 0.57 | 0.57 | 0.57 | |
Operating CF/Net income |
1.12 | 9.70 | 0.18 | 1.97 | |
Capex/Depreciation |
(0.65) | (0.77) | (0.59) | (0.59) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
25.01% | 25.12% | 23.35% | 24.92% | |
Intangible Assets out of Total Assets |
0.53 | 0.52 | 0.52 | 0.49 | |
Share Based Compensation of Revenue |
0.82% | 1.38% | 0.77% | 0.98% | |
Graham Net Nets |
(0.14) | (0.14) | (0.09) | (0.06) | |
Graham Number |
76.28 | 76.64 | 107.66 | 110.82 | |
Earnings Yield |
2.07% | 2.07% | 3.23% | 2.43% | |
Free Cash Flow Yield |
1.60% | 1.97% | 1.77% | 1.49% | |
Revenue per Share |
18.10 | 18.38 | 18.64 | 18.96 | |
Operating CF per Share |
1.40 | 1.71 | 0.98 | 3.36 | |
Capex per Share |
(0.53) | (0.64) | (0.46) | (0.46) | |
Free Cash Flow per Share |
0.87 | 1.07 | 0.51 | 2.90 | |
Cash per Share |
8.21 | 8.05 | 8.61 | 14.85 | |
Shareholders Equity per Share |
58.91 | 58.14 | 62.60 | 62.74 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
58.91 | 58.14 | 62.60 | 62.74 | |
Free Cash Flow |
10.41 | 12.89 | 6.16 | 34.91 | |
Working Capital |
317.88 | 319.93 | 324.31 | 322.24 | |
Capital Expenditures |
(6.42) | (7.66) | (5.59) | (5.52) | |
Net Current Asset Value |
(359.63) | (363.53) | (289.88) | (278.74) | |
EV/EBIT |
30.19 | 24.20 | 18.03 | 23.99 | |
Capex to Sales |
0.03 | 0.03 | 0.02 | 0.02 | |
Net Profit Margin |
6.92% | 0.96% | 29.82% | 8.97% | |
Price to Operating Income |
25.69 | 20.74 | 16.10 | 22.24 | |
| Other line items | |||||
Average Receivables |
142.68 | 164.90 | 174.79 | 172.80 | |
Average Payables |
77.10 | 80.58 | 76.92 | 84.05 | |
Average Inventory |
112.95 | 117.59 | 124.76 | 129.48 | |
Average Assets |
1,296.37 | 1,518.72 | 1,540.67 | 1,576.29 | |
Average Common Equity |
682.84 | 678.14 | 720.55 | 733.45 |
Columns are period end dates